CoChat

Intravitreal injections: past trends and future projections within a UK tertiary hospital

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Aims: To describe past trends and future projections for the number of intravitreal injections being administered at a large tertiary hospital in London, United Kingdom. Methods: Retrospective data from Moorfields Eye Hospital were collected using the electronic medical record system. Descriptive statistics were used to visualise overall trends. Time series forecasting was used to predict the number of injections that will be administered up to and including the year 2029. Results: The number of injections has increased nearly 11-fold from 2009 to 2019, with a total of 44,924 injections delivered in 2019. The majority of injections were given for the treatment of neovascular age-related macular degeneration. Aflibercept formed 87% of injections administered in 2019. The number of injections is predicted to continue to increase every year, with nearly 83,000 injections forecasted in the year 2029. Conclusion: The demand for intravitreal injections has increased substantially over the last decade and is predicted to further increase. Healthcare systems will need to adapt to accommodate the high demand. Other solutions may include longer-acting therapies to reduce the treatment burden.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41433-021-01646-3

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Historical trends. Number of patients that attended the intravitreal injection clinic every week (black), and the number of injections administered (grey), between August 2008 to December 2019 (inclusive), at Moorfields Eye Hospital. The annotations highlight when drugs became available on the Moorfields formulary and for which conditions.
Fig. 1 Historical trends. Number of patients that attended the intravitreal injection clinic every week (black), and the number of injections administered (grey), between August 2008 to December 2019 (inclusive), at Moorfields Eye Hospital. The annotations highlight when drugs became available on the Moorfields formulary and for which conditions.CC BY · PubMed Central
Fig. 2 Number of injections given per year from 2008–2019. a Stratified by retinal condition, (b) stratified by drug.
Fig. 2 Number of injections given per year from 2008–2019. a Stratified by retinal condition, (b) stratified by drug.CC BY · PubMed Central
Fig. 3 Weekly number of injections per condition. Number of injections given per week for neovascular age-related macular degeneration (AMD), macular oedema secondary to retinal vein occlusion (RVO), and diabetic macular oedema.
Fig. 3 Weekly number of injections per condition. Number of injections given per week for neovascular age-related macular degeneration (AMD), macular oedema secondary to retinal vein occlusion (RVO), and diabetic macular oedema.CC BY · PubMed Central
Fig. 4 Bilateral treatment. Percentage of patient visits where injections were given bilaterally, stratified by retinal condition and year.
Fig. 4 Bilateral treatment. Percentage of patient visits where injections were given bilaterally, stratified by retinal condition and year.CC BY · PubMed Central
Fig. 5 Forecasting future trends. Actual number of monthly injections from 2008 to the end of 2019 (black). Forecasted number of monthly injections for a 10-year period from 2020 to the end of 2029 with shaded 95% confidence intervals (grey).
Fig. 5 Forecasting future trends. Actual number of monthly injections from 2008 to the end of 2019 (black). Forecasted number of monthly injections for a 10-year period from 2020 to the end of 2029 with shaded 95% confidence intervals (grey).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 1

  1. Wickham L, Hay G, Hamilton R, Wooding J, Tossounis H, da Cruz L, et al. The impact of COVID policies on acute. Ophthalmol Serv-experiences Moorfields Eye Hospital NHS Found Trust Eye. 2020;34:1189–92.

Cited by

See all 84

Metadata

Authors
Chopra, R., Preston, G. C., Keenan, T. D. L., Mulholland, P., Patel, P. J., Balaskas, K., Hamilton, R. D., & Keane, P. A.
Affiliations
Moorfields Eye Hospital NHS Foundation Trust (GB)
Corresponding author
Keane, Pearse A.
Venue
Eye
Published
2021-06-25
Volume
36
Issue
7
Pages
1373-1378
ISSN
  • 0078-5334 (ISSN-L)
  • 0950-222X
  • 1476-5454
OpenAlex
W3173934490
Cited by
83
References
26
Citations by year
2026: 22 · 2025: 16 · 2024: 21 · 2023: 12 · 2022: 12
FWCI
10.30
Type
journal article
Language
en
Open access
Licence
Locations
  • Eye (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Ulster University Research Portal (Ulster University) (submittedVersion, cc-by)
Funders
  • College of Optometrists
  • U.S. Department of Health & Human Services | National Institutes of Health
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
intravitreal injection, neovascular age-related macular degeneration, aflibercept, time series forecasting, healthcare resource planning, Moorfields Eye Hospital
MeSH terms
Ranibizumab, Follow-Up Studies, Humans, Population Growth, Recombinant Fusion Proteins, Retrospective Studies, Visual Acuity, Treatment Outcome, Angiogenesis Inhibitors, Receptors, Vascular Endothelial Growth Factor, Intravitreal Injections, Tertiary Care Centers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intravitreal injections: past trends and future projections within a UK tertiary hospital. https://app.cochat.ai/papers/10.1038/s41433-021-01646-3
The paper
Chopra, R., Preston, G. C., Keenan, T. D. L., Mulholland, P., Patel, P. J., Balaskas, K., Hamilton, R. D., & Keane, P. A. (2022). Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye. https://doi.org/10.1038/s41433-021-01646-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.